From Liston Street Pulse:
Shares of Cyclacel Pharmaceuticals Inc. (CYCC), a developer of therapies that harness the power of the immune system to treat cancer and other serious illnesses, have surged in trading today after the company announced study results. The company said that updated data showed that sapacitabine has activity against a majority […]
The post Cyclacel Pharmaceuticals Surges on Study Results appeared first on Liston Street Pulse.
Created by Stock Researching | Dec 13, 2016
Created by Stock Researching | Dec 04, 2016
Created by Stock Researching | Dec 02, 2016
Created by Stock Researching | Nov 19, 2016
Created by Stock Researching | Nov 10, 2016
Created by Stock Researching | Oct 05, 2015